Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,304.00    -92.00 (-6.59%)
Bid:
1,298.00
Ask:
1,310.00
Spread: 12.00 (0.924%)
Market Cap: £597.63m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Share Options

14 Aug 2013 10:38

RNS Number : 6754L
Cohort PLC
14 August 2013
 



14 August 2013 AIM: CHRT

PRESS RELEASE

COHORT PLC ("Cohort")

Share Options

Option Grant

Cohort announces that on 13 August 2013 the following approved options over ordinary shares of 10 pence each were granted to Cohort directors pursuant to the Cohort plc Savings Related Share Option Scheme established on 16 February 2006 (and approved by HM Revenue & Customs on 10 April 2006) ("SAYE Scheme"):

Director

Number of shares under this option

Exercise Price (pence)

Total number of shares under the SAYE Scheme following grant

AS Thomis

2,330

154.5

6,041

SR Walther

5,825

154.5

15,103

 

The options are made pursuant to three year savings contracts.

Option Exercise

Cohort announces that it has issued and allotted 170,164 new ordinary shares of 10p each in the capital of Cohort pursuant to the exercise of share options under the Cohort plc 2006 Share Option Scheme and the SAYE Scheme.

Following this exercise, Cohort's issued share capital consists of 40,958,616 ordinary shares of 10p each with voting rights. Cohort does not hold any shares in treasury.

Therefore, the total number of voting rights in Cohort is 40,958,616. This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Cohort under the FCA's Disclosure and Transparency Rules.

Application has been made for admission of these shares to trading on AIM and dealings in the new ordinary shares are expected to commence on 19 August 2013.

 

Ends

 

For further information, please contact

 

Cohort plc

 

Andrew Thomis, Chief Executive

Simon Walther, Finance Director

+44 (0)118 909 0390

 

Investec

Keith Anderson, Daniel Adams

+44 (0)20 7597 5970

MHP Communications

Reg Hoare, Vicky Watkins, Ben Griffiths

+44 (0)20 3128 8100

 

 

Cohort plc (www.cohortplc.com) (@Cohortplc)

 

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through three market-facing subsidiary companies:

Ÿ MASS (www.mass.co.uk) - a specialist systems house with considerable experience in the defence market and a focus on information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

 

Ÿ SCS (www.scs-ltd.co.uk) - a defence technical advisory business, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

 

Ÿ SEA (www.sea.co.uk) - an advanced surveillance systems and software house with hardware development capability operating in the defence, space and transport market sectors. Acquired by Cohort in October 2007.

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 500 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Lincolnshire and Somerset.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFWSULFDSEDA
Date   Source Headline
28th Feb 20237:00 amRNSRecording of Investor Presentation
24th Feb 20231:25 pmRNSBlock listing Interim Review
17th Feb 202310:13 amRNSDirector/PDMR Shareholding
15th Feb 202310:30 amRNSDirector/PDMR Shareholding
1st Feb 20239:42 amRNSTotal Voting Rights
27th Jan 20233:30 pmRNSEBT Purchase of Shares
20th Jan 20237:00 amRNSInvestor Presentation
16th Jan 20237:00 amRNSInterim Report 2022
3rd Jan 20234:00 pmRNSEBT Purchase of Shares
3rd Jan 20233:30 pmRNSTotal Voting Rights
22nd Dec 20225:14 pmRNSEBT Purchase of Shares
14th Dec 20224:51 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSHalf Year Results
5th Dec 202211:30 amRNSNotice of Results
30th Nov 20224:41 pmRNSSecond Price Monitoring Extn
30th Nov 20224:36 pmRNSPrice Monitoring Extension
30th Nov 20223:18 pmRNSTotal Voting Rights
24th Nov 20227:00 amRNSMASS awarded contract extension
31st Oct 20224:50 pmRNSTotal Voting Rights
21st Oct 20224:40 pmRNSDirector/PDMR Shareholding
21st Oct 20229:44 amRNSDirector/PDMR Shareholding
11th Oct 20222:15 pmRNSDirector/PDMR Shareholding
5th Oct 20224:46 pmRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 202211:04 amRNSTotal Voting Rights
29th Sep 20225:18 pmRNSDirector/PDMR Shareholding
28th Sep 20227:00 amRNSResult of AGM
27th Sep 20227:00 amRNSAGM Statement and First Quarter Update
8th Sep 20227:00 amRNSDirector/PDMR Shareholding
7th Sep 20227:00 amRNSSEA AWARDED UPGRADE CONTRACT WITH MOD
31st Aug 20222:15 pmRNSTotal Voting Rights
25th Aug 20227:00 amRNSAnnual Report and Notice of Annual General Meeting
24th Aug 20229:30 amRNSBlock listing Interim Review
12th Aug 202210:04 amRNSDirector Share Awards and Shareholdings
11th Aug 202212:06 pmRNSTransfer of Shares
10th Aug 20222:59 pmRNSDirector/PDMR Shareholding
29th Jul 202212:40 pmRNSTotal Voting Rights
28th Jul 20227:00 amRNSDirectorate Change
28th Jul 20227:00 amRNSPreliminary Results
26th Jul 202210:35 amRNSNotice of Results
25th Jul 20221:17 pmRNSHolding(s) in Company
19th Jul 20224:10 pmRNSHolding(s) in Company
19th Jul 20227:00 amRNSCohort plc extends banking facility
30th Jun 20223:21 pmRNSTotal Voting Rights
31st May 20221:31 pmRNSTotal Voting Rights
26th May 20227:00 amRNSFull Year Trading Update
29th Apr 20224:15 pmRNSTotal Voting Rights
25th Apr 20227:00 amRNSHolding(s) in Company
22nd Apr 20223:35 pmRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSDirector/PDMR Shareholding
4th Apr 20223:00 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.